SIMS STRATEGIES, LLC

Lobbying for GLAXOSMITHKLINE, INC. · Pharmaceutical Company

Filing 3rd Quarter - Report

3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · Senate · $40,000.00 income · posted Oct 20, 2025

Lobbying activity 2

Pharmacy

Issues related to prescription drugs, vaccines, and Pharmacy Benefit Managers.

Medicare/Medicaid

Issues related to prescription drugs, vaccines, and Pharmacy Benefit Managers.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.